Multiple endocrine neoplasia type 2 risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 22: Line 22:
! style="background: #F5F5F5;" | Children with c-''RET'' codon 609, 768, 790, 791, 804
! style="background: #F5F5F5;" | Children with c-''RET'' codon 609, 768, 790, 791, 804
and 891 mutations  
and 891 mutations  
! style="background: #F5F5F5;" | Less aggressive and slowly growing [[medullary thyroid cancer]]
! style="background: #F5F5F5;" | Less aggressive and slowly growing [[medullary thyroid cancer]]-
| style="padding: 5px 5px; background: #F5F5F5;" colspan="2"|<small>Adapted from Marquard J, Eng C. Multiple Endocrine Neoplasia Type 2. 1999 Sep 27 [Updated 2015 Jun 25]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1257/<ref>{{Cite journal| author = [[Jessica Marquard]] & [[Charis Eng]]
| title = Multiple Endocrine Neoplasia Type 2
| year = 1993
| month =
| pmid = 020301434
}}</ref>
|}
|}
|}
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 00:49, 29 September 2015

Multiple endocrine neoplasia type 2 Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple endocrine neoplasia type 2 from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Criteria

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Multiple endocrine neoplasia type 2 risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple endocrine neoplasia type 2 risk factors

CDC on Multiple endocrine neoplasia type 2 risk factors

Multiple endocrine neoplasia type 2 risk factors in the news

Blogs on Multiple endocrine neoplasia type 2 risk factors

Directions to Hospitals Treating Multiple endocrine neoplasia type 2

Risk calculators and risk factors for Multiple endocrine neoplasia type 2 risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [3]

Overview

Common risk factor in the development of multiple endocrine neoplasia type 2 is family history.

Risk Factors

  • Family history is the common risk factor in the development of multiple endocrine neoplasia type 2.[1]
  • During the Seventh International Multiple Endocrine Neoplasia Meeting in Gubbio in 1999, the risk of medullary thyroid cancer has been stratified in three categories according to the mutations of c-RET as following.
Risk Stratification
Gene Risk
Children with multiple endocrine neoplasia type 2B and/or c-RET codon 883, 918,

922

Highest risk of aggressive medullary thyroid cancer
Children with any c-RET codon 611, 618, 620 or 634

mutations

High risk of medullary thyroid cancer
Children with c-RET codon 609, 768, 790, 791, 804

and 891 mutations

Less aggressive and slowly growing medullary thyroid cancer- Adapted from Marquard J, Eng C. Multiple Endocrine Neoplasia Type 2. 1999 Sep 27 [Updated 2015 Jun 25]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1257/[2]

|}

References

  1. [1] Wikipedia Multiple endocrine neoplasia type 2; MEN2
  2. Jessica Marquard & Charis Eng (1993). "Multiple Endocrine Neoplasia Type 2". PMID 020301434.

Template:WikiDoc Sources